COMPANY NEWS LenioBio welcomes Dr. Desmond Schofield as Head Of Business Development mAlbe and LenioBio announce a new strategic collaboration LenioBio partners with AffinityAI to Accelerate Discovery of Novel Complex Proteins LenioBio secures € 3.7M of EU4Health Funding to Develop ALiCE® for Cost-effective and Rapid Production of Protein-based Medicines LenioBio appoints Sabine Imamoglu as Chief Operating Officer LenioBio launches ALiCE® HTPE, driving next-generation Antibody Discovery LenioBio partners with Avantor, bringing cutting edge cell-free protein expression technology to researchers across Europe LenioBio Earns Prestigious EU STEP Seal: A Signal of Excellence for Investors LenioBio accesses tailor-made business opportunities LenioBio Collaborates with ReciBioPharm to Scale Up ALiCE® Technology and Expedite Vaccine Production Touchlight and LenioBio collaborate to accelerate development of protein therapeutics for pandemic response Labscoop and LenioBio Announce Strategic Partnership to Enhance Access of Scalable Cell-Free Protein Synthesis Technology Across North America. Plant-Based ALiCE® Technology Could Shave Weeks Off Vaccine Production LenioBio Appoints CTO and CCO to Spearhead Growth and Innovation LenioBio appoints Hugh Watson as Chief Financial Officer LenioBio announces new CEO LenioBio announces appointment of Professor Daniel Bracewell to its Scientific Advisory Board LenioBio reaches industrial-scale with its high-yield eukaryotic platform for cell-free protein synthesis A breakthrough in Biopharmaceutical Protein Production – LenioBio announces a new proprietary Cell Line Devoid of Plant Glycans LenioBio awarded prestigious Eurostars grant LenioBio closes its Series-A Extension round and strengthens its Board of Directors. LenioBio Announces a Scientific Advisory Board Composed of Experts within the Field of Biotechnology LenioBio GmbH and Fraunhofer IME to Advance Novel Protein Discoveries through a License Agreement Protein Science to Advance through LenioBio and Dow AgroSciences License Agreement LenioBio Wins Prestigious Horizon 2020 SME/2 Grant
